source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-08 22:30:00
| null |
THE WESTERN UNION COMPANY PRESENTS AT MONEY20/20 U.S.A., OCT-27-2019 . VENUE: LAS VEGAS, NEVADA, UNITED STATES. SPEAKERS: KHALID FELLAHI, PRESIDENT OF CONSUMER MONEY TRANSFER, NICOLE VOGRIN, CHIEF CORPORATE AFFAIRS & COMMUNICATIONS OFFICER, REBECCA LOEVENGUTH, VP OF TRANSFORMATION.
|
THE WESTERN UNION COMPANY PRESENTS AT MONEY20/20 U.S.A., OCT-27-2019
|
WU
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-06 22:30:00
| null |
THE WESTERN UNION COMPANY, Q3 2019 EARNINGS CALL, OCT 31, 2019
|
THE WESTERN UNION COMPANY, Q3 2019 EARNINGS CALL, OCT 31, 2019
|
WU
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-09-30 20:30:00
| null |
WESTERN UNION CO FILES FOR POTENTIAL DEBT SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.
|
WESTERN UNION CO FILES FOR POTENTIAL DEBT SHELF OFFERING; SIZE NOT DISCLOSED
|
WU
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-26 11:30:00
| null |
58.COM REPORTS FIRST QUARTER 2020 UNAUDITED FINANCIAL RESULTS.Q1 REVENUE FELL 15.5 PERCENT TO RMB 2.56 BILLION.QTRLY EPS OF RMB 5.41.QTRLY EARNINGS PER ADS RMB 10.82.AS OF MARCH 31, 2020, COMPANY HAD CASH AND CASH EQUIVALENTS, TERM DEPOSITS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS OF RMB12,547.3 MILLION.
|
58.COM SAYS Q1 REVENUE FELL 15.5%
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-15 11:30:00
| null |
58.COM ENTERS INTO A DEFINITIVE AGREEMENT FOR GOING-PRIVATE TRANSACTION.58.COM INC - DEAL FOR APPROXIMATELY US$8.7 BILLION.58.COM INC - MERGER CONSIDERATION REPRESENTS A PREMIUM OF 19.9% TO CLOSING PRICE OF CO'S ADSS ON APRIL 1, 2020.58.COM INC - ENTERED INTO A DEFINITIVE AGREEME WITH QUANTUM BLOOM GROUP LTD.58.COM - INTENDS TO FUND MERGER THROUGH COMBINATION OF CASH CONTRIBUTIONS FROM INVESTORS, ROLLOVER EQUITY CONTRIBUTIONS, PROCEEDS FROM LOAN FACILITIES.58.COM - CO'S BOARD, ACTING UPON UNANIMOUS RECOMMENDATION OF COMMITTEE OF INDEPENDENT & DISINTERESTED DIRECTORS ESTABLISHED BY BOARD APPROVED MERGER AGREEMENT.58.COM INC - CONSORTIUM OF INVESTORS TO ACQUIRE CO INCLUDES WARBURG PINCUS ASIA LLC, GENERAL ATLANTIC SINGAPORE FUND PTE. LTD..58.COM - EACH CLASS A, CLASS B ORDINARY SHARE WILL BE CANCELLED & CEASE TO EXIST IN EXCHANGE FOR RIGHT TO RECEIVE US$28.00 IN CASH WITHOUT INTEREST.58.COM - EACH OUTSTANDING ADS, SHARE REPRESENTED BY SUCH ADSS, WILL BE CANCELLED IN EXCHANGE FOR RIGHT TO RECEIVE US$56.00 IN CASH WITHOUT INTEREST.
|
58.COM ENTERS INTO A DEFINITIVE AGREEMENT FOR GOING-PRIVATE TRANSACTION
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-07 10:30:00
| null |
58.COM'S ZHUAN ZHUAN USED-GOODS TRADING PLATFORM TO ACQUIRE OPERATOR OF ZHAOLIANGJI APP.58.COM INC - ACQUIRE 100% EQUITY INTEREST IN SHENZHEN WANSHIFU TECHNOLOGY.58.COM INC - DEAL FOR COMBINATION OF CASH IN AMOUNT OF RMB360 MILLION & NEWLY ISSUED ZHUAN SPIRIT HOLDINGS LIMITED SHARES.
|
58.COM'S ZHUAN ZHUAN USED-GOODS TRADING PLATFORM TO ACQUIRE OPERATOR OF ZHAOLIANGJI APP
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-04 10:30:00
| null |
CARMIGNAC SAYS 58.COM BOARD SHOULD REJECT PRELIMINARY PROPOSAL LETTER FROM JINBO YAO, WARBURG PINCUS ASIA, GENERAL ATLANTIC SINGAPORE, OCEAN LINK.
|
CARMIGNAC SAYS 58.COM SHOULD REJECT PRELIMINARY PROPOSAL LETTER FROM JINBO YAO, OTHERS
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-02 14:30:00
| null |
58.COM ANNOUNCES RECEIPT OF A PRELIMINARY NON-BINDING PROPOSAL TO ACQUIRE THE COMPANY.58.COM INC - BOARD GOT A PRELIMINARY NON-BINDING PROPOSAL LETTER FROM OCEAN LINK PARTNERS LIMITED TO ACQUIRE ALL OF OUTSTANDING ORDINARY SHARES.58.COM INC - PROPOSAL FOR US$27.5 IN CASH PER CLASS A OR CLASS B ORDINARY SHARE.58.COM INC - BOARD PLANS TO EVALUATE PROPOSED TRANSACTION.58.COM -OCEAN LINK INTENDS TO FUND CONSIDERATION PAYABLE IN TRANSACTION WITH EQUITY CAPITAL.58.COM - OCEAN LINK INTENDS TO FUND CONSIDERATION PAYABLE IN TRANSACTION ADDITIONAL MEMBERS IT ACCEPTS INTO A CONSORTIUM OF BUYERS, POSSIBLY DEBT CAPITAL.
|
58.COM ANNOUNCES RECEIPT OF A PRELIMINARY NON-BINDING PROPOSAL TO ACQUIRE THE COMPANY
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-24 11:30:00
| null |
58.COM PURCHASES B2B ONLINE USED CAR AUCTION BUSINESS FROM UXIN.58.COM INC - DEAL FOR US$105 MILLION.
|
58.COM PURCHASES B2B ONLINE USED CAR AUCTION BUSINESS FROM UXIN
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-11 22:30:00
| null |
58.COM REPORTS FOURTH QUARTER AND FISCAL YEAR 2019 UNAUDITED FINANCIAL RESULTS.QTRLY BASIC AND DILUTED EARNINGS PER ADS ATTRIBUTABLE TO ORDINARY SHAREHOLDERS WERE RMB17.45 (US$2.50) AND RMB17.28 (US$2.48).SEES Q1 2020 REVENUE RMB 2.16 BILLION TO RMB 2.26 BILLION.Q4 REVENUE ROSE 15.1 PERCENT TO RMB 4.156 BILLION.Q4 NON-GAAP BASIC AND DILUTED EARNINGS PER ADS5 ATTRIBUTABLE TO ORDINARY SHAREHOLDERS WERE RMB32.61(US$4.67) AND RMB32.30(US$4.63).FOR Q1 OF 2020, 58.COM'S BUSINESS HAS BEEN SIGNIFICANTLY IMPACTED BY OUTBREAK OF COVID-19.
|
58.COM REPORTS Q4 EARNING PER ADS OF $2.48
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-17 22:30:00
| null |
58.COM INC. PROVIDED EARNINGS GUIDANCE FOR THE FOURTH QUARTER OF 2019. BASED ON THE COMPANY'S CURRENT OPERATIONS, TOTAL REVENUES FOR THE FOURTH QUARTER OF 2019 ARE EXPECTED TO BE BETWEEN RMB 4.05 BILLION AND RMB 4.15 BILLION. THIS REPRESENTS A YEAR-OVER-YEAR INCREASE OF 12% TO 15% IN RENMINBI.
|
58.COM INC. PROVIDES EARNINGS GUIDANCE FOR THE FOURTH QUARTER OF 2019
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-10 22:30:00
| null |
58.COM INC. ANNOUNCED THAT THEY WILL REPORT Q3, 2019 RESULTS AT 9:00 AM, CHINA STANDARD TIME ON NOV 19, 2019
|
58.COM INC. TO REPORT Q3, 2019 RESULTS ON NOV 19, 2019
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-17 22:30:00
| null |
TONGZHONG MEDIA ANNOUNCED THAT IT HAS RECEIVED $2,830,000 IN ITS SERIES A ROUND OF FUNDING LED BY 58.COM INC. (NYSE:WUBA) ON OCTOBER 18, 2019. THE TRANSACTION INCLUDED PARTICIPATION FROM OTHER INVESTORS.
|
TONGZHONG MEDIA ANNOUNCED THAT IT HAS RECEIVED $2.83 MILLION IN FUNDING FROM 58.COM INC., AND OTHER INVESTORS
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-09-30 09:30:00
| null |
58.COM ANNOUNCES ENTRY INTO DEFINITIVE AGREEMENTS TO CONVERT PROFIT PARTICIPATION RIGHT AND ACQUIRE SHARES OF GOLDEN PACER.58.COM INC - UPON COMPLETION OF DEALS, CO WILL HOLD ABOUT 32.6% OF SHARE CAPITAL OF GOLDEN PACER.58.COM INC - GOLDEN PACER ENTERED INTO DEFINITIVE AGREEMENTS WITH UXIN LIMITED.58.COM INC - GOLDEN PACER WILL ACQUIRE LOAN FACILITATION RELATED BUSINESS FROM UXIN; UXIN WILL RECEIVE CERTAIN NUMBER OF SHARES OF GOLDEN PACER.
|
58.COM ANNOUNCES ENTRY INTO DEFINITIVE AGREEMENTS TO CONVERT PROFIT PARTICIPATION RIGHT AND ACQUIRE SHARES OF GOLDEN PACER
|
WUBA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-07-18 08:30:00
| null |
INCREASES SELF-MINING BY 58% TO 7.9 EH/S AND OVER 200 MW OF CAPACITY BY YEAR END 2023 CREATES ONE OF THE MOST EFFICIENT AND PROFITABLE MINING FLEETS IN THE SECTOR BY COMBINING A FLEET EFFICIENCY OF 25.7 J/TH WITH LOW-COST 91% ZERO-CARBON POWER REPRESENTS THE FIRST LARGE-SCALE ORDER OF S19J XPS FROM BITMAIN EASTON, MD., JULY 18, 2023 (GLOBE NEWSWIRE) -- TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), OWNER AND OPERATOR OF VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY ANNOUNCED PLANS TO EXPAND ITS SELF-MINING CAPACITY TO 7.9 EH/S BY YEAR END WITH THE ASSOCIATED PURCHASE OF 18,500 OF THE NEXT GENERATION ANTMINER S19J XP BITCOIN MINING MACHINES FOR A TOTAL PRICE OF $75 MILLION.
|
TERAWULF ANNOUNCES 7.9 EH/S EXPANSION PLAN AND ASSOCIATED PURCHASE OF 18,500 S19J XP BITCOIN MINERS FROM BITMAIN
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-07-06 08:30:00
| null |
INCREASED HASHRATE CAPACITY BY 25% MONTH-OVER-MONTH TO 5.5 EH/S AS OF JUNE 30, 2023 SELF-MINED 347 BTC IN JUNE, AN 8% INCREASE OVER MAY, FOR A TOTAL OF 909 BTC MINED IN 2Q 2023 AND 1,441 BTC YEAR TO DATE EASTON, MD., JULY 06, 2023 (GLOBE NEWSWIRE) -- TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), OWNERS AND OPERATORS OF VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY PROVIDED AN UNAUDITED MONTHLY PRODUCTION AND OPERATIONS UPDATE FOR JUNE 2023.
|
TERAWULF ANNOUNCES JUNE 2023 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-22 08:30:00
| null |
INDUSTRY-LEADING POWER COST OF APPROXIMATELY $6.2K PER BITCOIN PRODUCED IN MAY 2023 NEAR-TERM ABILITY TO EXPAND CAPACITY BY UP TO 150 MW AT EXISTING SITES PROPRIETARY BITCOIN MINING FLEET POWERED BY MORE THAN 91% ZERO-CARBON ENERGY EASTON, MD., JUNE 22, 2023 (GLOBE NEWSWIRE) -- TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), OWNER AND OPERATOR OF VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY ANNOUNCED THE COMPANY HAS SUCCESSFULLY ACHIEVED 5.5 EH/S AND 160 MW OF OPERATING CAPACITY FOLLOWING THE COMPLETION OF BUILDING 2 AT ITS WHOLLY-OWNED LAKE MARINER FACILITY IN NEW YORK.
|
TERAWULF ACHIEVES 5.5 EH/S AND 160 MW OF BITCOIN MINING CAPACITY
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-05 16:05:00
| null |
SELF-MINED 323 BTC IN MAY, A 35% INCREASE OVER APRIL, FOR A TOTAL OF 1,094 BTC MINED YEAR TO DATE. INCREASED HASH RATE CAPACITY BY OVER 13% MONTH-OVER-MONTH TO 4.4 EH/S AS OF MAY 31, 2023.
|
TERAWULF ANNOUNCES MAY 2023 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-15 08:32:00
| null |
INCREASED HASHRATE CAPACITY BY 65% IN Q1 2023 TO 3.3 EH/S AS OF MARCH 31, 2023. SELF-MINED 533 BITCOIN IN Q1 2023, AN INCREASE OF 38% OVER THE BITCOIN SELF-MINED IN Q4 2022.
|
TERAWULF ANNOUNCES FIRST QUARTER 2023 RESULTS AND PROVIDES OPERATIONAL UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-04 08:15:00
| null |
EASTON, MD.--(BUSINESS WIRE)--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), OWNERS AND OPERATORS OF VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY PROVIDED AN UNAUDITED MONTHLY PRODUCTION AND OPERATIONS UPDATE FOR APRIL 2023. APRIL 2023 HIGHLIGHTS FULLY ENERGIZED ITS 50 MW STAKE AT THE NAUTILUS FACILITY, THE FIRST BITCOIN MINING FACILITY POWERED BY 100% NUCLEAR POWER IN THE U.S. SELF-MINED 239 BITCOIN IN APRIL WITH AN A.
|
TERAWULF ANNOUNCES APRIL 2023 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-20 13:00:00
| null |
EASTON, MD.--(BUSINESS WIRE)--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), OWNERS AND OPERATORS OF VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY ANNOUNCED THAT THE COMPANY HAS NOW FULLY ENERGIZED ITS 50-MW STAKE IN THE NAUTILUS CRYPTOMINE FACILITY, A JOINT VENTURE WITH CUMULUS COIN, LLC.
|
TERAWULF ANNOUNCES FULL DEPLOYMENT OF 50 MW AT THE NAUTILUS BITCOIN MINING FACILITY AHEAD OF SCHEDULE
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-06 08:15:00
| null |
EASTON, MD.
|
TERAWULF ANNOUNCES MARCH 2023 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-30 16:10:00
| null |
EASTON, MD.
|
TERAWULF REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS AND PROVIDES OPERATIONAL UPDATE
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-20 08:20:00
| null |
EASTON, MD.
|
TERAWULF ANNOUNCES IT HAS DEPLOYED BITMAIN MINERS AT THE NUCLEAR-POWERED NAUTILUS FACILITY
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-14 13:04:00
| null |
EASTON, MD.--(BUSINESS WIRE)---- $WULF #BITCOIN--TERAWULF ADDRESSES U.S.
|
TERAWULF ADDRESSES U.S. BANK CLOSURES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-08 08:10:00
| null |
EASTON, MD.
|
TERAWULF ANNOUNCES FEBRUARY 2023 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-06 08:20:00
| null |
EASTON, MD.
|
TERAWULF ANNOUNCES ENERGIZATION AND RAPID DEPLOYMENT OF MINING OPERATIONS AT THE NAUTILUS FACILITY IN PENNSYLVANIA
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-02 11:10:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY ANNOUNCED THAT TODAY ANNOUNCED THAT THE COMPANY'S CO-FOUNDER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER, PAUL PRAGER, HAS ISSUED AN OPEN LETTER TO SHAREHOLDERS.
|
TERAWULF ISSUES AN OPEN LETTER TO SHAREHOLDERS FROM CHAIRMAN AND CEO
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-01-09 08:30:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TODAY TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, PROVIDED AN UNAUDITED MONTHLY PRODUCTION AND OPERATIONS UPDATE FOR DECEMBER 2022.
|
TERAWULF ANNOUNCES DECEMBER 2022 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-01-03 16:05:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, IS PLEASED TO RELEASE THE FOLLOWING OPEN LETTER TO SHAREHOLDERS, LENDERS AND OTHER STAKEHOLDERS FROM PAUL PRAGER, TERAWULF'S CHAIRMAN AND CHIEF EXECUTIVE OFFICER.
|
TERAWULF ISSUES AN OPEN LETTER FROM CHAIRMAN AND CEO
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-12-12 08:30:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY ANNOUNCED THAT IT HAS SUCCESSFULLY RESTRUCTURED ITS PREVIOUSLY ANNOUNCED PURCHASE AGREEMENT WITH BITMAIN TECHNOLOGIES LIMITED (“BITMAIN”), ENABLING THE COMPANY TO SIGNIFICANTLY EXPAND ITS SELF-MINING CAPACITY AND FULLY UTILIZE 160 MW OF ITS AVAILABLE MINING CAPACITY EXPECTED IN Q1 2023. THE COMPANY ALSO ANNOUNCED THAT IT HAS RAISED NEW CAPITAL TO REPAY THE CONVERTIBLE PROMISSORY NOTE (THE “ADVANCE”) WITH YA II PN, LTD. (“YORKVILLE”) IN FULL AND EXPECTS TO SIMULTANEOUSLY ISSUE A NOTICE TO YORKVILLE TO TERMINATE THE ACCOMPANYING STANDBY EQUITY PURCHASE AGREEMENT (“SEPA”).
|
TERAWULF SIGNIFICANTLY INCREASES EXPECTED Q1 2023 SELF-MINING HASH RATE AT NO ADDITIONAL COST AND ANNOUNCES REPAYMENT OF CERTAIN DEBT
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-12-05 08:30:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY PROVIDED AN UNAUDITED MONTHLY PRODUCTION AND OPERATIONS UPDATE FOR NOVEMBER 2022.
|
TERAWULF ANNOUNCES NOVEMBER 2022 PRODUCTION AND OPERATIONS UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-28 08:30:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY PROVIDED AN OPERATIONAL UPDATE AND MORE DETAIL REGARDING ITS COST-REDUCTION INITIATIVES THAT ARE UNDERWAY TO ENSURE THE COMPANY MAINTAINS GREATER RESILIENCY IN A LOW-PRICED BITCOIN ENVIRONMENT. THE COMPANY ALSO REITERATED THAT THE LAKE MARINER FACILITY IS NOT IMPACTED BY THE TWO-YEAR MORATORIUM ON NEW PERMITS FOR FOSSIL FUEL POWERED PROOF-OF-WORK MINING, WHICH WAS RECENTLY SIGNED INTO LAW BY THE GOVERNOR OF THE STATE OF NEW YORK.
|
TERAWULF UPDATES MINING OPERATIONS AND COST-REDUCTION INITIATIVES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-14 16:20:00
| null |
EASTON, MD.--( BUSINESS WIRE )--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY REPORTED FINANCIAL RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2022 AND PROVIDED CERTAIN OPERATIONAL UPDATES.
|
TERAWULF ANNOUNCES THIRD QUARTER 2022 RESULTS AND PROVIDES OPERATIONAL UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-10-10 08:30:00
| null |
EASTON, MD.--(BUSINESS WIRE)---- $WULF #BITCOIN--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, TODAY ANNOUNCED IT HAS INCREASED ITS TOTAL OPERATING CAPACITY TO MORE THAN 1.6 EH/S AT ITS LAKE MARINER FACILITY IN NEW YORK. THE COMPANY ALSO ANNOUNCED $17 MILLION OF NEW CAPITAL, COMPRISED OF AN APPROXIMATE $9.5 MILLION NON-BROKERED PRIVATE PLACEMENT OF EQUITY (THE “PRIVATE PLACE
|
TERAWULF INCREASES OPERATING CAPACITY TO >1.6 EH/S AND ANNOUNCES $17 MILLION OF INCREMENTAL CAPITAL
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-19 08:30:00
| null |
EASTON, MD.--(BUSINESS WIRE)---- $WULF #BITCOIN--TERAWULF ANNOUNCES OPERATION OF NEARLY 12,000 MINERS AT ITS LAKE MARINER FACILITY
|
TERAWULF ANNOUNCES OPERATION OF NEARLY 12,000 MINERS AT ITS LAKE MARINER FACILITY
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-29 16:15:00
| null |
EASTON, MD.--(BUSINESS WIRE)---- $WULF #BITCOIN--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES VERTICALLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, IS PLEASED TO ANNOUNCE THAT THE COMPANY AND A SUBSIDIARY OF TALEN ENERGY CORPORATION HAVE REACHED AN AGREEMENT TO AMEND THEIR EXISTING JOINT VENTURE AGREEMENT (THE “NAUTILUS JV”) FOR THE NAUTILUS CRYPTOMINE BITCOIN MINING FACILITY (THE “NAUTILUS CRYPTOMINE FACILITY”), WHICH IS LOCA
|
TERAWULF ANNOUNCES AMENDMENTS TO ITS NAUTILUS JOINT VENTURE AGREEMENT WITH TALEN ENERGY
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-15 17:35:00
| null |
EASTON, MD.--(BUSINESS WIRE)--TERAWULF ANNOUNCES SECOND QUARTER 2022 RESULTS AND FINANCIAL AND OPERATIONAL UPDATES
|
TERAWULF ANNOUNCES SECOND QUARTER 2022 RESULTS AND FINANCIAL AND OPERATIONAL UPDATES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-07-05 08:30:00
| null |
EASTON, MD.--(BUSINESS WIRE)---- $WULF #BITCOIN--TERAWULF INC. (NASDAQ: WULF) (“TERAWULF” OR THE “COMPANY”), WHICH OWNS AND OPERATES FULLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 91% ZERO-CARBON ENERGY, ANNOUNCED IT HAS ENTERED INTO A FIRST AMENDMENT TO THE LOAN AGREEMENT WITH ITS EXISTING LENDER GROUP FOR AN ADDITIONAL $50 MILLION OF DEBT. THE COMPANY INTENDS TO USE NET PROCEEDS TOWARDS COMPLETING THE DATACENTER INFRASTRUCTURE AT ITS LAKE MARINER FACILITY IN NEW YORK AND NAUTILUS CRYP
|
TERAWULF ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED $50 MILLION ADD-ON LOAN FACILITY AND INITIAL DELIVERY OF 3,000 S19 XP ANTMINERS FROM BITMAIN
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-13 16:38:00
| null |
CAPITAL SUPPORTS PROGRESS TOWARDS ACHIEVING GOAL OF 210 MW OF INFRASTRUCTURE BY YE 2022 COMPANY TO HOST PREVIOUSLY SCHEDULED BUSINESS UPDATE CALL AT 5:00 PM E.T. TODAY EASTON, MD.
|
TERAWULF ANNOUNCES RECENT FINANCINGS AND NEAR-TERM RAMP OF DIGITAL ASSET INFRASTRUCTURE
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-23 16:15:00
| null |
EASTON, MD. , MAY 23, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF" OR THE "COMPANY"), WHICH OWNS AND OPERATES FULLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 90% ZERO-CARBON ENERGY, TODAY ANNOUNCED ITS PARTICIPATION IN THE FOLLOWING UPCOMING INVESTOR EVENTS.
|
TERAWULF ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR EVENTS
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-16 17:01:00
| null |
BRINGS 22 YEARS OF FINANCIAL EXPERIENCE IN PRINCIPAL INVESTING AND ADVISORY ROLES TO THE TERAWULF TEAM EASTON, MD. , MAY 16, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF" OR THE "COMPANY"), WHICH OWNS AND OPERATES FULLY INTEGRATED, DOMESTIC BITCOIN MINING FACILITIES POWERED BY MORE THAN 90% ZERO-CARBON ENERGY, TODAY ANNOUNCED THAT PATRICK FLEURY HAS BEEN APPOINTED CHIEF FINANCIAL OFFICER, EFFECTIVE TODAY.
|
TERAWULF APPOINTS PATRICK FLEURY AS CHIEF FINANCIAL OFFICER
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-10 09:27:00
| null |
ON TRACK TO BEGIN MINING IN THIRD QUARTER 2022 EASTON, MD. , MAY 10, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF" OR THE "COMPANY"), WHICH OWNS AND OPERATES FULLY INTEGRATED BITCOIN MINING FACILITIES IN THE UNITED STATES POWERED BY MORE THAN 90% ZERO-CARBON ENERGY, TODAY ISSUED THE FOLLOWING STATEMENT REGARDING THE NAUTILUS CRYPTOMINE FACILITY IN PENNSYLVANIA, WHICH IS A 50/50 JOINT VENTURE BETWEEN TERAWULF AND TALEN ENERGY CORPORATION ("TALEN"): THE NAUTILUS CRYPTOMINE FACILITY, WHICH IS A JOINT VENTURE BETWEEN TERAWULF AND CUMULUS COIN, LLC, A SUBSIDIARY OF TALEN, REMAINS ON TRACK TO BEGIN BITCOIN MINING OPERATIONS IN THE THIRD QUARTER OF 2022.
|
TERAWULF ISSUES STATEMENT REITERATING PLANS FOR NAUTILUS CRYPTOMINE
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-12 09:26:00
| null |
EASTON, MD., APRIL 12, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ:WULF) ("TERAWULF" OR THE "COMPANY") TODAY ANNOUNCED THAT IT PRICED A PUBLIC OFFERING OF ITS COMMON STOCK (THE "OFFERING") FOR GROSS PROCEEDS OF APPROXIMATELY $20.6 MILLION, BEFORE DEDUCTING UNDERWRITING DISCOUNTS AND COMMISSIONS AND OFFERING EXPENSES PAYABLE BY THE COMPANY.
|
TERAWULF INC. ANNOUNCES PRICING OF $20.6 MILLION PUBLIC OFFERING OF COMMON STOCK
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-11 17:20:00
| null |
EASTON, MD. , APRIL 11, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF" OR THE "COMPANY"), WHICH OWNS AND OPERATES FULLY INTEGRATED ENVIRONMENTALLY CLEAN BITCOIN MINING FACILITIES IN THE UNITED STATES, TODAY ANNOUNCED THAT IT IS COMMENCING AN UNDERWRITTEN PUBLIC OFFERING OF ITS COMMON STOCK (THE "OFFERING").
|
TERAWULF INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-25 17:30:00
| null |
EASTON, MD., MARCH 25, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF" OR THE "COMPANY"), WHICH WAS FORMED TO OWN AND OPERATE FULLY INTEGRATED ENVIRONMENTALLY CLEAN BITCOIN MINING FACILITIES IN THE UNITED STATES, TODAY ANNOUNCED ITS PARTICIPATION IN THE FOLLOWING UPCOMING INVESTOR EVENTS.
|
TERAWULF ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR EVENTS
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-17 16:48:00
| null |
EXPECTS LAKE MARINER TO HAVE 4,000 BITCOIN MINERS OPERATIONAL BY LATE APRIL ANTICIPATES OPERATIONS TO COMMENCE AT NAUTILUS CRYPTOMINE FACILITY DURING THIRD QUARTER 2022 EXPECTS TO ACHIEVE 23 EXAHASH PER SECOND, OR 800 MEGAWATTS ("MW"), OF MINING CAPACITY DEPLOYED BY 2025 EASTON, MD. , MARCH 17, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF" OR THE "COMPANY"), WHICH WAS FORMED TO OWN AND OPERATE FULLY INTEGRATED ENVIRONMENTALLY CLEAN BITCOIN MINING FACILITIES IN THE UNITED STATES, TODAY ANNOUNCED SIGNIFICANT PROGRESS BUILDING OUT ITS MINING OPERATIONS AND ESTABLISHING ITS DIGITAL ASSET INFRASTRUCTURE.
|
TERAWULF ANNOUNCES SIGNIFICANT PROGRESS BUILDING OUT MINING OPERATIONS AND ESTABLISHING DIGITAL ASSET INFRASTRUCTURE
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-16 08:05:00
| null |
INVESTMENT BY EXISTING SHAREHOLDERS, NEW DIRECTORS AND COMPANY LEADERSHIP REFLECT CONTINUED CONFIDENCE IN MINING OPERATIONS RAMP COMPANY TO PROVIDE A BUSINESS UPDATE ON THURSDAY, MARCH 17 AT 5 P.M. ET EASTON, MD.
|
TERAWULF ANNOUNCES $15 MILLION CAPITAL CONTRIBUTION
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-14 08:30:00
| null |
EASTON, MD., FEB. 14, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF"), WHICH WAS FORMED TO OWN AND OPERATE FULLY INTEGRATED ENVIRONMENTALLY CLEAN BITCOIN MINING FACILITIES IN THE UNITED STATES, TODAY ANNOUNCED IT HAS APPOINTED WILLIAM "SANDY" HARRISON AS VICE PRESIDENT OF INVESTOR RELATIONS, EFFECTIVE IMMEDIATELY.
|
TERAWULF NAMES WILLIAM "SANDY" HARRISON AS VICE PRESIDENT OF INVESTOR RELATIONS
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-10 08:30:00
| null |
EASTON, MD., JAN. 10, 2022 /PRNEWSWIRE/ -- TERAWULF INC. (NASDAQ: WULF) ("TERAWULF") TODAY ANNOUNCED THE FORMATION OF THE TERAWULF CHARITABLE FOUNDATION, A PRIVATE, PHILANTHROPIC ORGANIZATION FOCUSED ON FUNDING AND PARTICIPATING IN SOCIAL HEALTH, ENVIRONMENTAL AND SUSTAINABILITY PROGRAMS.
|
TERAWULF LAUNCHES PHILANTHROPIC FOUNDATION FOCUSED ON IMPROVING SOCIAL HEALTH, THE ENVIRONMENT AND SUSTAINABILITY INITIATIVES
|
WULF
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-26 08:30:00
| null |
CAMBRIDGE, MASS., JUNE 26, 2023 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE RNA MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, TODAY ANNOUNCED THAT THE COMPANY HAS BEEN ADDED TO THE SMALL-CAP RUSSELL 2000® AND BROAD-MARKET ALL-CAP RUSSELL 3000® INDEXES AS PART OF THE ANNUAL RECONSTITUTION, EFFECTIVE AFTER THE U.S. MARKET OPENS TODAY, JUNE 26, 2023.
|
WAVE LIFE SCIENCES JOINS THE RUSSELL 2000® AND RUSSELL 3000® INDEXES
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-23 07:30:00
| null |
POTENT AND DURABLE TARGET ENGAGEMENT OBSERVED ACROSS COHORTS, INCLUDING WITH 10 MG DOSES ADMINISTERED EVERY 12 WEEKS WHICH WERE ALSO GENERALLY SAFE AND WELL-TOLERATED
|
WAVE LIFE SCIENCES ANNOUNCES TOPLINE RESULTS FROM PHASE 1B/2A FOCUS-C9 STUDY OF WVE-004 FOR C9ORF72-ASSOCIATED AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-16 08:30:00
| null |
PRESENTATIONS INCLUDE NEW DATA SHOWING WVE-006 IMPROVED MARKERS OF LIVER DISEASE IN MICE; WVE-006 IS A FIRST-IN-CLASS RNA EDITING THERAPEUTIC FOR ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD) WHICH IS DESIGNED TO RESTORE HEALTHY, WILD-TYPE AAT PROTEIN
|
WAVE LIFE SCIENCES TO HIGHLIGHT LEADING RNA EDITING CAPABILITY AND MULTIMODAL DISCOVERY AND DEVELOPMENT PLATFORM AT ASGCT 26TH ANNUAL MEETING
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-03 07:30:00
| null |
EMERGING LEADER IN RNA MEDICINES WITH MULTI-MODAL DISCOVERY AND DEVELOPMENT PLATFORM AND FIRST-IN-CLASS RNA EDITING PROGRAMS
|
WAVE LIFE SCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-26 08:30:00
| null |
CAMBRIDGE, MASS., APRIL 26, 2023 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE GENETIC MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, WILL HOST A LIVE WEBCAST AND CONFERENCE CALL AT 8:30 A.M. ET ON WEDNESDAY, MAY 3, 2023, TO REVIEW THE COMPANY'S FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATES.
|
WAVE LIFE SCIENCES FIRST QUARTER 2023 FINANCIAL RESULTS SCHEDULED FOR MAY 3, 2023
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-20 08:30:00
| null |
PUBLISHED PRECLINICAL DATA DEMONSTRATE UNPRECEDENTED AGO2 LOADING FOLLOWING ADMINISTRATION OF SINGLE SUBCUTANEOUS SIRNA DOSE, LEADING TO IMPROVED POTENCY AND DURABILITY IN VIVO VERSUS COMPARATOR SIRNA FORMATS
|
WAVE LIFE SCIENCES ANNOUNCES NUCLEIC ACIDS RESEARCH PUBLICATION HIGHLIGHTING POTENTIAL BEST-IN-CLASS SIRNAS DESIGNED WITH WAVE PLATFORM CHEMISTRY
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-22 07:30:00
| null |
ACHIEVED CLINICAL VALIDATION OF PRISM PLATFORM IN 2022 – DEMONSTRATED ABILITY TO POTENTLY AND DURABLY ENGAGE RNA TARGETS AND TRANSLATE PRECLINICAL DATA TO THE CLINIC
|
WAVE LIFE SCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-12-19 07:37:00
| null |
53% MEAN EXON SKIPPING AND
|
WAVE LIFE SCIENCES PROVIDES POSITIVE UPDATE ON PROOF-OF-CONCEPT STUDY FOR WVE-N531 IN DUCHENNE MUSCULAR DYSTROPHY
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-12-13 07:30:00
| null |
WAVE RECEIVES UPFRONT PAYMENT OF $170 MILLION IN CASH AND EQUITY, ALSO ELIGIBLE TO RECEIVE MILESTONE PAYMENTS AND ROYALTIES
|
WAVE LIFE SCIENCES AND GSK ANNOUNCE COLLABORATION TO DRIVE DISCOVERY AND DEVELOPMENT OF OLIGONUCLEOTIDE THERAPEUTICS FOCUSING ON NOVEL GENETIC TARGETS
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-10 07:30:00
| null |
ANNOUNCED POSITIVE UPDATE IN THIRD QUARTER FROM SELECT-HD TRIAL IN HD; SINGLE DOSES OF WVE-003 APPEARED GENERALLY SAFE AND WELL-TOLERATED AND SUGGESTED ALLELE-SELECTIVE REDUCTION OF MHTT PROTEIN IN CSF
|
WAVE LIFE SCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-10-03 08:30:00
| null |
SIX PRESENTATIONS AND POSTERS BETWEEN OTS AND ESGCT MEETINGS WILL HIGHLIGHT WAVE'S OLIGONUCLEOTIDE CHEMISTRY ADVANCEMENTS AS WELL AS RNA EDITING AND RNAI CAPABILITIES
|
WAVE LIFE SCIENCES TO HIGHLIGHT ADVANCEMENTS FROM PRISM PLATFORM AT UPCOMING SCIENTIFIC CONGRESSES
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-28 13:30:00
| null |
WVE-006 IS THE MOST ADVANCED CANDIDATE FOR AATD DESIGNED TO RESTORE FUNCTIONAL WILD-TYPE AAT PROTEIN AND REDUCE Z-AAT PROTEIN AGGREGATION WITH POTENTIAL FOR DISEASE MODIFICATION IN BOTH LUNG AND LIVER PHENOTYPES
|
WAVE LIFE SCIENCES HIGHLIGHTS THERAPEUTIC POTENTIAL FOR WVE-006 FOR ALPHA-1 ANTITRYPSIN DEFICIENCY AND PROGRESS BRINGING RNA EDITING TO THE CLINIC DURING ANALYST AND INVESTOR EVENT
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-20 07:30:00
| null |
SINGLE DOSES OF WVE-003 APPEAR GENERALLY SAFE AND WELL-TOLERATED
|
WAVE LIFE SCIENCES ANNOUNCES POSITIVE UPDATE FROM PHASE 1B/2A SELECT-HD TRIAL WITH INITIAL RESULTS INDICATING ALLELE-SELECTIVE TARGET ENGAGEMENT WITH WVE-003 IN HUNTINGTON'S DISEASE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-16 08:30:00
| null |
FOCUS ON WVE-006, A FIRST-IN-CLASS RNA EDITING DEVELOPMENT CANDIDATE FOR AATD, AND FEATURE AATD EXPERT PRESENTATION FOCUS ON WVE-006, A FIRST-IN-CLASS RNA EDITING DEVELOPMENT CANDIDATE FOR AATD, AND FEATURE AATD EXPERT PRESENTATION
|
WAVE LIFE SCIENCES TO HOST ANALYST AND INVESTOR VIRTUAL EVENT, “TOWARDS THE CLINIC: SPOTLIGHT ON RNA EDITING FOR AATD,” ON SEPTEMBER 28, 2022
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-11 07:30:00
| null |
WVE-006 ANNOUNCED AS INVESTIGATIONAL DEVELOPMENT CANDIDATE FOR AATD WITH CTA SUBMISSIONS EXPECTED IN 2023; FIRST-IN-CLASS RNA EDITING CANDIDATE AND MOST ADVANCED PROGRAM CURRENTLY IN DEVELOPMENT USING AN OLIGONUCLEOTIDE TO HARNESS AN ENDOGENOUS ENZYME FOR EDITING
|
WAVE LIFE SCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-14 09:00:00
| null |
CAMBRIDGE, MASS., JUNE 14, 2022 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE GENETIC MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, ANNOUNCED TODAY THE PRICING OF AN UNDERWRITTEN OFFERING (THE “OFFERING”) OF 25,464,483 OF ITS ORDINARY SHARES AT AN OFFERING PRICE OF $2.15 PER ORDINARY SHARE, AND, TO RA CAPITAL MANAGEMENT, L.P. IN LIEU OF ORDINARY SHARES, PRE-FUNDED WARRANTS TO PURCHASE UP TO 7,093,656 ORDINARY SHARES AT AN OFFERING PRICE OF $2.1499 PER PRE-FUNDED WARRANT, WHICH REPRESENTS THE PER SHARE OFFERING PRICE FOR THE ORDINARY SHARES LESS THE $0.0001 PER SHARE EXERCISE PRICE FOR EACH PRE-FUNDED WARRANT.
|
WAVE LIFE SCIENCES ANNOUNCES PRICING OF $70.0 MILLION UNDERWRITTEN OFFERING
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-12 07:30:00
| null |
DELIVERED FIRST CLINICAL DATA DEMONSTRATING TARGET ENGAGEMENT AND TRANSLATION OF PN CHEMISTRY'S IMPACT IN CLINIC; ADAPTING ONGOING PHASE 1B/2A FOCUS-C9 CLINICAL TRIAL TO OPTIMIZE DOSE LEVEL AND FREQUENCY, WITH ADDITIONAL SINGLE AND MULTIDOSE DATA EXPECTED THROUGHOUT 2022
|
WAVE LIFE SCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-25 08:30:00
| null |
PRECLINICAL DATA PUBLISHED IN MOLECULAR THERAPY NUCLEIC ACIDS DEMONSTRATE THAT WVE-004 POTENTLY REDUCES C9ORF72 TRANSCRIPTIONAL VARIANTS AND POLY(GP) DIPEPTIDE REPEAT PROTEINS IN MICE FOR AT LEAST SIX MONTHS WHILE MAINTAINING C9ORF72 PROTEIN LEVELS
|
WAVE LIFE SCIENCES ANNOUNCES PUBLICATION OF FOUNDATIONAL PRECLINICAL DATA SUPPORTING DEVELOPMENT OF WVE-004 FOR C9ORF72-ASSOCIATED ALS AND FTD
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-04 07:30:00
| null |
REDUCTIONS IN POLY(GP), A KEY DISEASE BIOMARKER INDICATING TARGET ENGAGEMENT, OBSERVED ACROSS ALL TREATMENT GROUPS AFTER SINGLE DOSES
|
WAVE LIFE SCIENCES ANNOUNCES POSITIVE UPDATE TO ONGOING PHASE 1B/2A FOCUS-C9 STUDY DRIVEN BY POTENT, DURABLE REDUCTIONS OF POLY(GP) WITH LOW, SINGLE DOSES OF WVE-004
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-15 08:30:00
| null |
PRESENTATION AT OPT 2022 TO HIGHLIGHT AATD PROGRAM, INCLUDING REDUCTION OF LIVER AGGREGATES WITH REPEAT AIMER DOSING OUT TO 19 WEEKS
|
WAVE LIFE SCIENCES TO HIGHLIGHT RNA BASE EDITING MODALITY AND ALPHA-1 ANTITRYPSIN DEFICIENCY PROGRAM AT UPCOMING SCIENTIFIC AND INDUSTRY MEETINGS
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-07 11:14:00
| null |
PUBLISHED DATA DEMONSTRATE POTENT, DURABLE, AND SPECIFIC EDITING AND POTENTIAL FOR THERAPEUTIC APPLICATIONS IN LIVER USING A SUBCUTANEOUS GALNAC-CONJUGATED OLIGONUCLEOTIDE APPROACH
|
WAVE LIFE SCIENCES ANNOUNCES NATURE BIOTECHNOLOGY PUBLICATION HIGHLIGHTING FIRST RNA BASE EDITING IN NON-HUMAN PRIMATES USING AN ENDOGENOUS ENZYME
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-03 07:30:00
| null |
CLINICAL DATA FROM MULTIPLE NOVEL, PN-MODIFIED STEREOPURE OLIGONUCLEOTIDES FOR ALS/FTD, DMD, AND HD EXPECTED IN 2022
|
WAVE LIFE SCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-02 16:05:00
| null |
WAVE PAPER ON PN CHEMISTRY FOR SILENCING IN THE CNS, AND THE IMPLICATIONS FOR OLIGONUCLEOTIDES MORE BROADLY, DESIGNATED AS A BREAKTHROUGH ARTICLE BY NUCLEIC ACIDS RESEARCH
|
WAVE LIFE SCIENCES ANNOUNCES TWO PAPERS IN THE JOURNAL NUCLEIC ACIDS RESEARCH DESCRIBING HOW PN BACKBONE CHEMISTRY MODIFICATIONS ENHANCE THE PHARMACOLOGICAL EFFECTS OF OLIGONUCLEOTIDES
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-25 11:07:00
| null |
NEW YORK, JAN. 25, 2022 /PRNEWSWIRE/ -- THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF) AND THE ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION (AFTD) ANNOUNCED TODAY THAT THEY HAVE PARTNERED TO SUPPORT WAVE LIFE SCIENCES' FOCUS-C9 PHASE 1B/2A CLINICAL TRIAL INVESTIGATING WVE-004 AS A POTENTIAL TREATMENT FOR C9ORF72-ASSOCIATED FRONTOTEMPORAL DEGENERATION (C9-FTD), AS WELL AS AMYOTROPHIC LATERAL SCLEROSIS (C9-ALS). THE PARTNERSHIP PROVIDES AN INVESTMENT FROM ADDF AND AFTD THAT WILL SUPPORT THE EVALUATION OF FLUID BIOMARKERS, FUNCTIONAL ASSESSMENTS, AND DIGITAL BIOMARKERS IN FOCUS-C9, POTENTIALLY LEADING TO CLINICALLY MEANINGFUL ENDPOINTS TO INFORM DEVELOPMENT OF TREATMENTS FOR FTD.
|
ADDF AND AFTD PARTNER TO SUPPORT WAVE LIFE SCIENCES' FTD AND ALS CLINICAL PROGRAM
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-10 07:30:00
| null |
STRENGTHENED BALANCE SHEET WITH APPROXIMATELY $52 MILLION; FOCUSING ADDITIONAL INVESTMENT IN RNA EDITING PROGRAMS LED BY HEPATIC EDITING
|
WAVE LIFE SCIENCES REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-18 17:00:00
| null |
AMENDMENT TO ONGOING COLLABORATION ALLOWS WAVE TO ADVANCE OR PARTNER CNS PROGRAMS, INCLUDING THOSE USING ADAR EDITING
|
WAVE LIFE SCIENCES AND TAKEDA AMEND CNS COLLABORATION
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-07 16:05:00
| null |
CAMBRIDGE, MASS., SEPT. 07, 2021 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE GENETIC MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, ANNOUNCED TODAY THAT PAUL BOLNO, MD, MBA, PRESIDENT AND CHIEF EXECUTIVE OFFICER, IS SCHEDULED TO GIVE A PRE-RECORDED PRESENTATION AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE, WHICH WILL BE MADE AVAILABLE FOR ON-DEMAND VIEWING ON MONDAY, SEPTEMBER 13, 2021 AT 7:00 A.M. ET.
|
WAVE LIFE SCIENCES TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-05 07:30:00
| null |
DOSING UNDERWAY IN FOCUS-C9 CLINICAL TRIAL OF WVE-004 IN C9-ALS / C9-FTD – FIRST OLIGONUCLEOTIDE USING PN BACKBONE CHEMISTRY MODIFICATIONS IN CLINICAL STUDY
|
WAVE LIFE SCIENCES REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-02 16:52:00
| null |
FIRST PROOF-OF-CONCEPT IN VIVO DATA FOR RNA EDITING USING ENDOGENOUS ADAR ENZYMES IN ALPHA-1 ANTITRYPSIN DEFICIENCY
|
WAVE LIFE SCIENCES ANNOUNCES PROOF-OF-CONCEPT PRECLINICAL DATA FOR ADAR EDITING PROGRAM IN ALPHA-1 ANTITRYPSIN DEFICIENCY
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-28 08:30:00
| null |
CAMBRIDGE, MASS., MAY 28, 2021 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE GENETIC MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, ANNOUNCED TODAY THAT PAUL BOLNO, MD, MBA, PRESIDENT AND CHIEF EXECUTIVE OFFICER, IS SCHEDULED TO GIVE A PRESENTATION AT THE JEFFERIES VIRTUAL HEALTHCARE CONFERENCE ON WEDNESDAY, JUNE 2, 2021 AT 11:30 A.M. ET. DR. BOLNO WILL PROVIDE A CORPORATE UPDATE AND DISCUSS WAVE'S PIPELINE PROGRAMS, INCLUDING THE FIRST IN VIVO DATA FROM THE COMPANY'S ADAR EDITING DISCOVERY PROGRAM FOR ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD).
|
WAVE LIFE SCIENCES TO PRESENT AT JEFFERIES VIRTUAL HEALTHCARE CONFERENCE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-13 07:30:00
| null |
CLINICAL TRIALS UNDERWAY WITH NEXT-GENERATION CANDIDATES INCORPORATING PN CHEMISTRY
|
WAVE LIFE SCIENCES REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-10 16:05:00
| null |
CAMBRIDGE, MASS., MAY 10, 2021 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE GENETIC MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, ANNOUNCED TODAY THAT PAUL BOLNO, MD, MBA, PRESIDENT AND CHIEF EXECUTIVE OFFICER IS SCHEDULED TO GIVE A PRESENTATION AT THE RBC CAPITAL MARKETS GLOBAL HEALTHCARE VIRTUAL CONFERENCE ON WEDNESDAY, MAY 19, 2021 AT 4:15 P.M. ET.
|
WAVE LIFE SCIENCES TO PRESENT AT RBC CAPITAL MARKETS GLOBAL HEALTHCARE VIRTUAL CONFERENCE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-29 16:05:00
| null |
MHTT RESULTS FROM PRECISION-HD TRIALS DO NOT SUPPORT FURTHER DEVELOPMENT OF WVE-120102 AND WVE-120101
|
WAVE LIFE SCIENCES PROVIDES UPDATE ON PHASE 1B/2A PRECISION-HD TRIALS
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-19 08:00:00
| null |
CAMBRIDGE, MASS., MARCH 19, 2021 (GLOBE NEWSWIRE) -- WAVE LIFE SCIENCES LTD. (NASDAQ: WVE), A CLINICAL-STAGE GENETIC MEDICINES COMPANY COMMITTED TO DELIVERING LIFE-CHANGING TREATMENTS FOR PEOPLE BATTLING DEVASTATING DISEASES, ANNOUNCED TODAY THAT PAUL BOLNO, MD, MBA, PRESIDENT AND CHIEF EXECUTIVE OFFICER AND MICHAEL PANZARA, MD, MPH, CHIEF MEDICAL OFFICER AND HEAD OF THERAPEUTICS DISCOVERY AND DEVELOPMENT ARE SCHEDULED TO PARTICIPATE VIRTUALLY IN AN ANALYST-LED FIRESIDE CHAT AT THE THIRD ANNUAL STIFEL CNS DAY ON WEDNESDAY, APRIL 1, 2021 AT 11:30 A.M. ET.
|
WAVE LIFE SCIENCES TO PRESENT AT THE THIRD ANNUAL STIFEL CNS DAY
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-04 07:00:00
| null |
STRONG EXECUTION IN 2020 SETS STAGE FOR ADVANCING FIVE CLINICAL PROGRAMS AND NOVEL ADAR EDITING MODALITY IN 2021
|
WAVE LIFE SCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-09 07:30:00
| null |
RESULTS FROM ALL COHORTS OF PRECISION-HD1 AND PRECISION-HD2 CLINICAL TRIALS AND INITIAL OLE DATA ON TRACK FOR 1Q 2021
|
WAVE LIFE SCIENCES REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-10 11:30:00
| null |
WAVE LIFE SCIENCES REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.C9ORF72 AND SNP3 CLINICAL TRIAL APPLICATIONS ON TRACK TO BE SUBMITTED IN 4Q 2020.AS OF JUNE 30, 2020, WAVE HAD $94.1 MILLION IN CASH AND CASH EQUIVALENTS.WAVE LIFE SCIENCES - EXPECTS EXISTING CASH & CASH EQUIVALENTS WITH EXPECTED & COMMITTED CASH, TO FUND OPERATING AND CAPEX REQUIREMENTS INTO Q4 OF 2021.QTRLY LOSS PER SHARE $1.15.Q2 EARNINGS PER SHARE VIEW $-0.97 -- REFINITIV IBES DATA.QTRLY REVENUE $3.0 MILLION VERSUS $7.6 MILLION.Q2 REVENUE VIEW $5.7 MILLION -- REFINITIV IBES DATA.
|
WAVE LIFE SCIENCES REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-11 09:30:00
| null |
WAVE LIFE SCIENCES REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.AS OF MARCH 31, HAD $120.9 MILLION IN CASH AND CASH EQUIVALENTS.WAVE LIFE SCIENCES - EXPECTS THAT EXISTING CASH AND CASH EQUIVALENTS, EXPECTED AND COMMITTED CASH WILL ENABLE CO TO FUND REQUIREMENTS INTO Q3 OF 2021.QTRLY LOSS PER SHARE $1.38.QTRLY REVENUE $4.2 MILLION VERSUS $3.0 MILLION.Q1 EARNINGS PER SHARE VIEW $-1.20 -- REFINITIV IBES DATA.
|
WAVE LIFE SCIENCES REPORTS Q1 LOSS PER SHARE OF $1.38
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-02 11:30:00
| null |
WAVE LIFE SCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.QTRLY LOSS PER SHARE $1.65.32 MG DATA FROM BOTH PRECISION-HD CLINICAL TRIALS ON TRACK FOR 2H 2020.TWO ADDITIONAL CNS PROGRAMS − SNP3 AND C9ORF72 − ON TRACK TO INITIATE CLINICAL DEVELOPMENT IN 2H 2020.WAVE LIFE SCIENCES- EXPECTS THAT EXISTING CASH, CASH EQUIVALENTS, WILL ENABLE CO TO FUND OPERATING, CAPEX REQUIREMENTS INTO Q3 OF 2021.Q4 EARNINGS PER SHARE VIEW $-1.43 -- REFINITIV IBES DATA.
|
WAVE LIFE SCIENCES REPORTS Q4 LOSS PER SHARE OF $1.65
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-06 20:30:00
| null |
WAVE LIFE SCIENCES LTD - ON FEBRUARY 6, CO IMPLEMENTED A COST REDUCTION PLAN.WAVE LIFE SCIENCES LTD - UNDER THIS COST REDUCTION PLAN, COMPANY WILL REDUCE ITS WORKFORCE BY APPROXIMATELY 22%.WAVE LIFE SCIENCES LTD - SEES ONE-TIME RESTRUCTURING CHARGES OF ABOUT $3.5 MILLION, MAJORITY OF WHICH IT EXPECTS TO PAY IN Q1 2020 RELATED TO PLAN.
|
WAVE LIFE SCIENCES LTD SAYS ON FEBRUARY 6, CO IMPLEMENTED A COST REDUCTION PLAN
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-21 14:30:00
| null |
RTW INVESTMENTS LP REPORTS 7.04% PASSIVE STAKE IN WAVE LIFE SCIENCES LTD AS OF JANUARY 9, 2020 - SEC FILING.
|
RTW INVESTMENTS LP REPORTS 7.04% PASSIVE STAKE IN WAVE LIFE SCIENCES
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-10 20:30:00
| null |
WAVE LIFE SCIENCES LTD - EFFECTIVE JANUARY 9, 2020, KEITH REGNANTE RESIGNED FROM HIS POSITION AS CFO.WAVE LIFE SCIENCES LTD - REGNANTE WILL ASSIST WITH TRANSITION OF HIS RESPONSIBILITIES THROUGH JANUARY 31, 2020.WAVE LIFE SCIENCES LTD - APPOINTED DAVID GAIERO AS INTERIM CHIEF FINANCIAL OFFICER.
|
WAVE LIFE SCIENCES- CFO KEITH REGNANTE RESIGNED EFFECTIVE JAN. 9
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-30 10:30:00
| null |
WAVE LIFE SCIENCES ANNOUNCES TOPLINE DATA AND ADDITION OF HIGHER DOSE COHORT IN ONGOING PHASE 1B/2A PRECISION-HD2 TRIAL IN HUNTINGTON’S DISEASE.WAVE LIFE SCIENCES LTD - WVE-120102 DEMONSTRATES STATISTICALLY SIGNIFICANT REDUCTION IN DISEASE-CAUSING MUTANT HTT PROTEIN IN CSF VERSUS. PLACEBO.WAVE LIFE SCIENCES LTD - NO DIFFERENCE IN TOTAL HTT PROTEIN OR NEUROFILAMENT LIGHT CHAIN IN TREATED PATIENTS VERSUS. PLACEBO.WAVE LIFE SCIENCES LTD - ADDITIONAL COHORT FOR WVE-120102 EXPECTED TO INITIATE IN JANUARY 2020.WAVE LIFE SCIENCES LTD - WVE-120102 WAS GENERALLY SAFE AND WELL TOLERATED ACROSS ALL COHORTS.WAVE LIFE SCIENCES LTD - DATA SUPPORT ADDITION OF HIGHER DOSE COHORTS, CO EXPECTS TO INITIATE A 32 MG COHORT IN JAN. 2020.WAVE - THERE WAS NO DIFFERENCE IN THTT VERSUS. PLACEBO; WVE-120102 MAY HAVE POTENTIALLY DIFFERENTIAL EFFECT ON HUNTINGTIN MEASURED BY MHTT, THTT ASSAYS.WAVE LIFE SCIENCES - THERE WERE NO SERIOUS ADVERSE EVENTS RELATED TO TREATMENT WITH WVE-120102 AND NO STUDY STOPPING RULES WERE MET.WAVE LIFE SCIENCES - TOPLINE RESULTS FROM PRECISION-HD1, INCLUDING THOSE FROM 32 MG COHORT, ARE NOW EXPECTED IN H2 2020.WAVE LIFE SCIENCES LTD - WILL CONTINUE TO EXPLORE POTENTIAL EFFECTS OF WVE-120102 ON HUNTINGTIN AS MEASURED BY MHTT & THTT ASSAYS, WITH HIGHER DOSES.
|
WAVE LIFE SCIENCES ANNOUNCES TOPLINE DATA AND ADDITION OF HIGHER DOSE COHORT IN ONGOING PHASE 1B/2A PRECISION-HD2 TRIAL IN HUNTINGTON’S DISEASE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-16 10:30:00
| null |
WAVE LIFE SCIENCES ANNOUNCES DISCONTINUATION OF SUVODIRSEN DEVELOPMENT FOR DUCHENNE MUSCULAR DYSTROPHY.WAVE LIFE SCIENCES LTD - COMPANY IS IMMEDIATELY DISCONTINUING TWO SUVODIRSEN TRIALS, OLE STUDY AND PHASE 2/3 DYSTANCE 51 TRIAL.WAVE LIFE SCIENCES LTD - SUSPENDING FURTHER DEVELOPMENT OF WVE-N531 FOR PATIENTS WITH MUTATIONS AMENABLE TO EXON 53 SKIPPING.WAVE LIFE SCIENCES - EXPECTS EXISTING CASH, CASH EQUIVALENTS TO ENABLE WAVE TO FUND ITS OPERATING, CAPITAL EXPENDITURE REQUIREMENTS INTO Q3 OF 2021.
|
WAVE LIFE SCIENCES ANNOUNCES DISCONTINUATION OF SUVODIRSEN DEVELOPMENT FOR DUCHENNE MUSCULAR DYSTROPHY
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-24 22:30:00
| null |
ASURAGEN, INC. AND WAVE LIFE SCIENCES HAVE ENTERED INTO AN AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF COMPANION DIAGNOSTICS FOR WAVE’S INVESTIGATIONAL ALLELE-SELECTIVE THERAPEUTIC PROGRAMS TARGETING HUNTINGTON’S DISEASE (HD). HD IS A DEVASTATING DISORDER CAUSED BY AN EXPANSION OF CAG REPEATS IN THE HTT GENE THAT RESULTS IN THE PROGRESSIVE BREAKDOWN OF NERVE CELLS IN THE BRAIN. IT DETERIORATES A PERSON'S PHYSICAL AND MENTAL ABILITIES, USUALLY DURING THEIR PRIME WORKING YEARS, IS ULTIMATELY FATAL AND HAS NO CURE. THE COMPANION DIAGNOSTICS THAT ASURAGEN WILL DEVELOP BUILD ON THE EXPERIENCE GAINED BY WAVE USING A SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) PHASING METHODOLOGY IN WAVE’S CURRENT CLINICAL TRIALS IN HD AND A PREVIOUS OBSERVATIONAL STUDY. THIS COLLABORATION AIMS TO USE ASURAGEN’S MARKET-LEADING REPETITIVE SEQUENCE DIAGNOSTIC EXPERTISE TO PROVIDE SCALABLE SNP PHASING TO SUPPORT POTENTIAL GLOBAL PHASE 3 DEVELOPMENT PROGRAMS AND FUTURE COMMERCIALIZATION AT A GLOBAL LEVEL.
|
ASURAGEN PARTNERS WITH WAVE LIFE SCIENCES TO DEVELOP COMPANION DIAGNOSTICS FOR HUNTINGTON’S DISEASE
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-05 20:30:00
| null |
WAVE LIFE SCIENCES REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.WAVE LIFE SCIENCES LTD - TOPLINE DATA FROM PRECISION-HD2 CLINICAL TRIAL EXPECTED BY YEAR-END.WAVE LIFE SCIENCES LTD - QTRLY LOSS PER SHARE $1.48.WAVE LIFE SCIENCES LTD - AS OF SEPTEMBER 30, 2019, WAVE HAD $209.0 MILLION IN CASH AND CASH EQUIVALENTS AS COMPARED TO $174.8 MILLION AS OF DECEMBER 31, 2018.
|
WAVE LIFE SCIENCES POSTS Q3 LOSS PER SHARE OF $1.48
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-04 22:30:00
| null |
WAVE LIFE SCIENCES LTD. HAS FILED A SHELF REGISTRATION IN THE AMOUNT OF $26.87 MILLION.
SECURITY NAME: ORDINARY SHARES
SECURITIES OFFERED: 1,000,000
TRANSACTION FEATURES: ESOP RELATED OFFERING
|
WAVE LIFE SCIENCES LTD. HAS FILED A SHELF REGISTRATION IN THE AMOUNT OF $26.87 MILLION.
|
WVE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-26 12:30:00
| null |
W V S FINANCIAL CORP - BOARD OF DIRECTORS AUTHORIZED ITS TWELFTH STOCK REPURCHASE PROGRAM.W V S FINANCIAL CORP - TWELFTH STOCK REPURCHASE PROGRAM IS TARGETING REPURCHASE OF UP TO 100,000 SHARES.
|
W V S FINANCIAL SAYS BOARD AUTHORIZED TWELFTH STOCK REPURCHASE PROGRAM
|
WVFC
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-28 22:30:00
| null |
WVS FINANCIAL CORP. ANNOUNCED THAT ITS BOARD OF DIRECTORS DECLARED A REGULAR $0.10 CASH DIVIDEND ON THE COMMON STOCK OF THE COMPANY, PAYABLE ON NOVEMBER 21, 2019 TO THE STOCKHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON NOVEMBER 11, 2019.
|
WVS FINANCIAL CORP. DECLARES REGULAR CASH DIVIDEND ON THE COMMON STOCK OF THE COMPANY, PAYABLE ON NOVEMBER 21, 2019
|
WVFC
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-24 22:30:00
| null |
WVS FINANCIAL CORP. ANNOUNCED EARNINGS RESULTS FOR THE FIRST QUARTER ENDED SEPTEMBER 30, 2019. FOR THE FIRST QUARTER, THE COMPANY ANNOUNCED NET INTEREST INCOME WAS USD 1.803 MILLION COMPARED TO USD 1.800 MILLION A YEAR AGO. NET INCOME WAS USD 793,000 COMPARED TO USD 748,000 A YEAR AGO. BASIC EARNINGS PER SHARE WAS USD 0.45 COMPARED TO USD 0.42 A YEAR AGO.
|
WVS FINANCIAL CORP. REPORTS EARNINGS RESULTS FOR THE FIRST QUARTER ENDED SEPTEMBER 30, 2019
|
WVFC
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.